HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.

AbstractBACKGROUND/AIMS:
Tetrahydrobiopterin is an essential cofactor for NOS enzymes to synthesize NO. It has been suggested that reduced intrahepatic tetrahydrobiopterin decreases intrahepatic NO and contributes to increase hepatic vascular resistance and portal pressure in cirrhosis. The main aim of the study was to evaluate the effect of tetrahydrobiopterin supplementation in portal pressure in CCl4 cirrhotic rats.
METHODS:
Cirrhotic rats received vehicle or tetrahydrobiopterin (10mg/kg/day i.p.) for 3 days. Hepatic and systemic hemodynamics and hepatic tetrahydrobiopterin, NOS activity and cGMP levels were measured. In addition, hepatic and systemic hemodynamics were evaluated in normal rats in which tetrahydrobiopterin deficiency was induced by administrating 2,4-diamino-6-hydroxy-pyrimidine (DAHP) for 8h.
RESULTS:
In cirrhotic rats, tetrahydrobiopterin administration increased liver NOS activity and cGMP levels and markedly and significantly reduced portal pressure. Amelioration of portal hypertension was associated with a normalization of arterial pressure. In normal rats DAHP decreased hepatic tetrahydrobiopterin and NOS activity and increased hepatic vascular tone. These effects of DAHP administration were corrected by tetrahydrobiopterin supplementation.
CONCLUSIONS:
The present study shows that tetrahydrobiopterin markedly reduces portal hypertension and improves systemic hemodynamics in cirrhotic rats. These data support the concept that tetrahydrobiopterin supplementation may represent a new therapeutic strategy for portal hypertension.
AuthorsVasilica Matei, Aina Rodríguez-Vilarrupla, Ramon Deulofeu, Héctor García-Calderó, Mercedes Fernández, Jaime Bosch, Joan-Carles Garcia-Pagán
JournalJournal of hepatology (J Hepatol) Vol. 49 Issue 2 Pg. 192-7 (Aug 2008) ISSN: 0168-8278 [Print] Netherlands
PMID18534709 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Hypoxanthines
  • Biopterin
  • Carbon Tetrachloride
  • Nitric Oxide Synthase
  • 2,4-diaminohypoxanthine
  • sapropterin
  • Cyclic GMP
Topics
  • Animals
  • Biopterin (analogs & derivatives, deficiency, pharmacology)
  • Carbon Tetrachloride (toxicity)
  • Cyclic GMP (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Hypertension, Portal (chemically induced, drug therapy, metabolism)
  • Hypoxanthines (pharmacology)
  • Liver (drug effects, enzymology)
  • Liver Cirrhosis (chemically induced, drug therapy, metabolism)
  • Male
  • Nitric Oxide Synthase (metabolism)
  • Rats
  • Rats, Wistar
  • Splanchnic Circulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: